Homology Medicines Inc.

NASDAQ: FIXX · Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM

Homology Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
77.97M 39.27M 33.99M 108.38M
Short-Term Investments
n/a 43.39M 141.04M 47.49M
Long-Term Investments
n/a n/a 25.81M 1.95M
Other Long-Term Assets
3.36M n/a -47.45M n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
3.91M 1.26M 5.99M 36.04M
Total Current Assets
81.88M 83.91M 181.01M 191.91M
Property-Plant & Equipment
7.09M 650K 21.64M 17.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
10.46M 222.21M 47.45M 19.81M
Total Assets
92.33M 306.12M 228.47M 211.72M
Account Payables
2.99M 3.23M 1.14M 2.37M
Deferred Revenue
n/a n/a 1.16M 3.21M
Short-Term Debt
3.1M 1.32M 1.56M 246K
Other Current Liabilities
10.38M 7.02M 18.71M 11.41M
Total Current Liabilities
16.46M 11.57M 22.58M 17.23M
Long-Term Debt
5.64M n/a 27.92M 23.69M
Other Long-Term Liabilities
64.56M n/a n/a n/a
Total Long-Term Liabilities
70.19M 221.56M 27.92M 24.84M
Total Liabilities
86.66M 233.13M 50.49M 42.07M
Total Debt
8.73M 1.32M 29.48M 23.93M
Common Stock
2K 6K 6K 6K
Retained Earnings
-234.81M -542.1M -429.14M -424.13M
Comprehensive Income
n/a -5K -404K -7K
Shareholders Equity
5.67M 72.99M 177.98M 169.65M
Total Investments
n/a 43.39M 166.85M 47.49M